UBI Pharma Competitors and Similar CompaniesClear all

UBI Pharma's competitors and similar companies include Getz Pharma, Corona Remedies, Enseval and Shandong Buchang Pharmaceuticals.

	UBI Pharma UBI Pharma is a company that develops, manufactures, and sells pharmaceutical products.	Getz Pharma Getz Pharma is a pharmaceutical company.	Corona Remedies Corona Remedies is a pharmaceutical company that manufactures tablets, capsules, syrups, ointments, gum paints, and injectables.	Enseval Enseval is a healthcare product distributor.	Shandong Buchang Pharmaceuticals Shandong Buchang Pharmaceuticals (山东步长制药股份有限公司) is a company that specializes in medicine and pharmacy.
Founding Date	Founding Date 2014	Founding Date 1995	Founding Date N/A	Founding Date 1973	Founding Date 1993
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy
Locations	Locations HQ	Locations Karachi, PK HQ Lagos, NG Pasig, PH Dubai, AE	Locations Ahmedabad, IN HQ Bavla, IN Bhayla, IN	Locations Jakarta, ID HQ	Locations Xi'an, CN HQ
Employees	Employees N/A	Employees 5,6991% increase	Employees 1,8091% increase	Employees 2,6001% increase	Employees 7,689
Financial
Revenue (est.)	Revenue (est.) NT$514.4m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥11.7b (FY, 2025)
Cost of goods	Cost of goods NT$48.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥4.4b (FY, 2025)
Gross profit	Gross profit NT$468.9m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥7.3b (FY, 2025)
Net income	Net income (NT$296.3m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income ¥192.3m (FY, 2025)